dc.contributor.author | Aldape, K | |
dc.contributor.author | Brindle, KM | |
dc.contributor.author | Chesler, L | |
dc.contributor.author | Chopra, R | |
dc.contributor.author | Gajjar, A | |
dc.contributor.author | Gilbert, MR | |
dc.contributor.author | Gottardo, N | |
dc.contributor.author | Gutmann, DH | |
dc.contributor.author | Hargrave, D | |
dc.contributor.author | Holland, EC | |
dc.contributor.author | Jones, DTW | |
dc.contributor.author | Joyce, JA | |
dc.contributor.author | Kearns, P | |
dc.contributor.author | Kieran, MW | |
dc.contributor.author | Mellinghoff, IK | |
dc.contributor.author | Merchant, M | |
dc.contributor.author | Pfister, SM | |
dc.contributor.author | Pollard, SM | |
dc.contributor.author | Ramaswamy, V | |
dc.contributor.author | Rich, JN | |
dc.contributor.author | Robinson, GW | |
dc.contributor.author | Rowitch, DH | |
dc.contributor.author | Sampson, JH | |
dc.contributor.author | Taylor, MD | |
dc.contributor.author | Workman, P | |
dc.contributor.author | Gilbertson, RJ | |
dc.date.accessioned | 2019-03-04T15:47:58Z | |
dc.date.issued | 2019-08-01 | |
dc.identifier.citation | Nature reviews. Clinical oncology, 2019, 16 (8), pp. 509 - 520 | |
dc.identifier.issn | 1759-4774 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/3130 | |
dc.identifier.eissn | 1759-4782 | |
dc.identifier.doi | 10.1038/s41571-019-0177-5 | |
dc.description.abstract | Despite decades of research, brain tumours remain among the deadliest of all forms of cancer. The ability of these tumours to resist almost all conventional and novel treatments relates, in part, to the unique cell-intrinsic and microenvironmental properties of neural tissues. In an attempt to encourage progress in our understanding and ability to successfully treat patients with brain tumours, Cancer Research UK convened an international panel of clinicians and laboratory-based scientists to identify challenges that must be overcome if we are to cure all patients with a brain tumour. The seven key challenges summarized in this Position Paper are intended to serve as foci for future research and investment. | |
dc.format | Print | |
dc.format.extent | 509 - 520 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | NATURE PUBLISHING GROUP | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | Humans | |
dc.subject | Brain Neoplasms | |
dc.title | Challenges to curing primary brain tumours. | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1038/s41571-019-0177-5 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2019-08 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Nature reviews. Clinical oncology | |
pubs.issue | 8 | |
pubs.notes | No embargo | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Paediatric Solid Tumour Biology and Therapeutics | |
pubs.publication-status | Published | |
pubs.volume | 16 | |
pubs.embargo.terms | No embargo | |
icr.researchteam | Paediatric Solid Tumour Biology and Therapeutics | |
dc.contributor.icrauthor | Chesler, Louis | |
dc.contributor.icrauthor | Workman, Paul | |